Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

Post time 2024-6-17 19:05:06

Title: Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

journal: The Lancet Neurology

Authors: Prof Mark W Parsons, PhD Vignan Yogendrakumar, PhD Prof Leonid Churilov, PhD Carlos Garcia-Esperon, PhD Prof Bruce C V Campbell, PhD Michelle L Russell, RN et al

Published date: June 13, 2024

DOI: 10.1016/S1474-4422(24)00206-0

PDF link: https://www.sciencedirect.com/science/article/abs/pii/S1474442224002060

Article link: https://www.sciencedirect.com/science/article/abs/pii/S1474442224002060

Article Source: https://www.sciencedirect.com/science/article/abs/pii/S1474442224002060

Post time 2024-6-17 19:05:07

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial